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Abstract: To determine serum D(-)-lactate
and NO levels in patients with acute
mesenteric ischemia. 22 patients (12 with
acute mesenteric ischemia, 10 with bowel
obstruction) and 12 control patients who
were operated due to goitre. Serum D(-)lactate and NO levels in acute mesenteric
ischemia cases compared to small bowel
obstruction cases and control patients.
Increased serum D(-)-lactate and NO levels in
serum levels of ischemic bowel were found to
be significantly increased compared to both
the cases with small bowel obstruction and
control subjects (for D(-)-lactate: p<0.01,
p<0.0001; for NO p<0.01, p<0.0001,
respectively).
Significant
correlations
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Introduction
Since only very few diagnostic tests are specific for
mesenteric infarction in its early stage, this disease has a
high mortality rate that has been reported as 85% in the
literature (1). The diagnosis of acute intestinal ischemia is
very difficult due to not only nonspecificity of sign and
symptoms of the disease but also the presence of
additional medical problems seen in most of the
patients(2). For solving this problem, many investigators
have attempted to find a simple laboratory test that could
identify ischemic bowel before irreversible damage
occurs. In this respect, Jamieson and colleagues reported
that serum phosphate levels were found to be increased
in dogs with severe intestinal necrosis (3) and some
investigators focused on intracellular enzymes released by
the ischemic bowel (4). Unfortunately, up to now, no
marker has been found to be useful in clinical studies (5).
Knowledge about the production of D-lactic acid by
bacteria, its absorption from the intestinal tract, and its
concentrations in various body fluids may help to identify
the significance of findings of this metabolite in an ill
patient (6).
NO is generated from L-arginine by the action of the

between serum D(-)-lactate and NO levels in
both acute mesenteric ischemia and small
bowel obstruction group (r=0.506, p<0.05,
and r=0.692, p<0.05, respectively). The
sensitivity and the specificity of the D(-)lactate assay were 75% and 90%,
respectively. The sensitivity and the specificity
of NO assay were 83% and 80% respectively.
The positive predictive values of the D(-)lactate and NO were 81% and 71%,
respectively. Determination of serum D(-)lactate and NO levels may be helpful in the
diagnosis of difficult acute mesenteric
ischemia cases.

enzyme NO synthase (NOS) in vascular and neural tissues
of many organs (7,8). It has a role in vasodilation, platelet
aggregation and acts as an effector molecule in mediating
cytotoxicity (8,9). NO is a lipophylic gase (8) and its
synthesis is stimulated by endotoxins and ischemic
conditions (10,11). Although several studies have shown
NO to be protective by acting as a vasodilator to prevent
long-term ischemia, some studies have suggested that NO
could contribute to ischemia/reperfusion (I/R) injury (12).
While NO, since it is physiologically vasodilatator, has a
role in protecting tissue in ischemic events, and since it is
chemically free radical, NO may occasionally be harmful to
tissue by producing secondary toxic products. In low
tissue O2 saturation condition, NO reduces ischemic
damage by increasing blood flow secondary to
vasodilating effect. In high tissue O2 saturation condition,
it leads to directly toxic metabolites to a cell by reacting
superoxide and forming some toxic substances such as
peroxynitrite (13).
D(-)-lactate is the stereoisomer of the mammalian
L(+)-lactate. D(-)-lactate is not produced by mammalian
tissue, but it may be unmetabolized or only slowly
metabolized by human tissues (14). In this study, we
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Materials and Methods
This study was carried out in the Department of
General Surgery, School of Medicine, Atatürk University.
A preoperative blood sample was obtained from 22
patients undergoing surgery for acute abdominal
emergencies including suspected acute mesenteric
ischemia. Blood samples were not analyzed for patients
who had abdominal pain and did not warrant a
laparatomy or for patients undergoing elective
laparatomy. As a control, blood samples were obtained
from 12 patients having non-abdominal elective surgery
for nodular goitre.
Serum D(-)-lactate levels were studied according to
Brandt et al's method. Firstly, serum samples were
deproteinized by perchloric acid and potassium hydroxide.
Then, serum D(-)-lactate level was detected using a
previously described spectrophotometric metod (15). In
this method, briefly, the absorbance of NADH formed
from NAD in the presence of L-lactate andLDH is read at
340 nm (Shimadzu Spectrophotometer UV-120-01). The
results are presented as g/L.
For serum levels of nitric oxide determination, the
serum samples obtained were deproteinized with
sulfosalicylic acid (35%). Then, nitrate (NO-3) in a
supernatant was reduced by cadmium column (100
mesh) to nitrite (NO-2) and the concentration of NO-2 was
determined with the Griess reaction (16). In this reaction,
the Griess reagent consisted of one part 0.1%
naphthylenediamine dihydrochloride and one part 1 %
sulfanilamide in 5% phosphoric acid, mixed together and
kept chilled. After incubation in a waterbath at 60˚C, the
color of the product dye was developed and its
absorbance was detected at 560 nm by
spectrophotometer. Standards of sodium nitrite and
sodium nitrate ranged from 10 to 60 nmol/mL. NO values
was given as NO-2 plus NO-3 in nmol/mL.
Stastical Analysis:
Mann-Whitney U test was used to determine statistical
significance between groups. The data are expressed as
mean ± SD. A p value of less than 0.05 was considered
stastically significant. Sensitivity, specificity and positive
predictive value were calculated according to standard
methods.
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Figure 1.

Serum D(-)-Lactate levels of ischemic bowel, small bowel
obstruction and control groups.
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aimed to investigate whether the determination of serum
D(-)-lactate and NO levels are useful markers for early
diagnosis of acute intestinal ischemia.
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Figure 2.

Serum NO levels of ischemic bowel, small bowel
obstruction and control groups.

Results
Twenty-two patients underwent exploratory
laparatomy. Mesenteric ischemia was found in twelve
patients, of whom eight had small bowel infarction and
four had small bowel and colonic infarction. The cause of
ischemia was presumed to be embolic in twelve of these
patients. Ten patients had a small bowell obstruction; that
was related to adhesion. In the control group, patients
underwent surgery for goitre but did not undergo
exploratory laparatomy.
Serum D(-)-lactate levels of patients with ischemic
bowel were found to be significantly increased compared
to both the cases with small bowel obstruction and with
control subjects (p<0.01, p<0.0001). Additionally, D(-)lactate levels of small bowel obstruction cases were
higher than those of the controls (p<0.0001) (Fig 1).
Patients with ischemic bowel had higher serum NO
values than those of the controls and of small bowel
obstruction (p<0.0001, p<0.01, respectively). NO levels
of small bowel obstruction cases were higher than those
of the controls (p<0.01) ( Fig 2 ). There were significant
correlations between serum NO and D(-)-lactate values
both in mesenteric ischemic group and small bowel
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obstruction group (r=0.506, p<0.05 , and r=0.692,
p<0.05, respectively).
Sensitivity is defined as the proportion of cases of
mesenteric ischemia correctly diagnosed, and specificity
as the proportion of diagnoses that mesenteric ischemias
indeed absent in patients without the condition. For a D()-lactate level greater than 0.033 g/L, the sensitivity and
the specificity of the D(-)-lactate assay were 75% and
90% respectively. For a NO level greater than 31
nmol/mL the sensitivity and the specificity of NO assay
were 83% and 80% respectively. For a D(-)-lactate level
greater than 0.033 g/L the positive predictive value was
81%. For a NO level greater than 31 nmol/mL, the
positive predictive value was 71%.
Discussion
Until now, most of the reports related to lactic
acidosis in human have referred only to L-lactic acidosis
which is frequently associated with colitis, infectious
diseases and malabsorption of carbohydrates. However,
D-lactic asidosis was paid attension in recent years (1719) and has been proposed that D(-)-lactate is produced
by bacterial metabolism of unabsorbed carbohydrate in
intestines. Mammalian tissues obey not produce D(-)lactate and only slowly metabolizes it (6). Because of the
resulting malabsorbtion of carbohydrates (19) large
amounts of D- and L- lactate are produced by intestinal
flora. With bacterial overgrowth, these metabolites are
produced not only from mono- and disaccharides such as
glucose and lactose (19,20) but also from starch, due to
fermentative activity of certain abundant intestinal grampositive rod-shaped bacteria (21) .
This study demonstrated that patients with
mesenteric ischemia have significantly elevated D(-)lactate levels in peripheral blood compared with patients
who have small bowel obstruction and control groups.
There are several reasons that D(-)-lactate might be a
useful early predictor of acute mesenteric ischemia.
Among these reasons, some conditions such as the
overproduction of D(-)-lactate by bacteria in
gastrointestinal tract, efflux of bacteria and the products
of their metabolism including D(-)-lactate into the
circulation due to injured mucosa seen in ischemic events,

decrease in normal defense mechanism againts bacteria in
intestinal ischemic conditions, and lack of enzyme systems
rapidly metabolizing D(-)-lactate might be responsible.
Studies have implicated NO as a mediator, messenger,
or regulator of cell function in physiologic states that
include vascular tone, platelet function, septic shock (10).
Masuda et al. (22) have demonstrated that endogenous
NO may be an essential protective factor in the
pathogenesis of ethanol-induced gastric mucosal injury
through improved mucosal hemodynamics. There is an
alternative approach to the explanation of the protective
mechanism of NO that may function as a chemical barrier
to cytotoxic free radicals because NO could be a natural
extracellular scavenger of O2-. It seems that superoxide
radicals possibly from endothelial cells themselves and/or
Kupffer cells contribute the endothelial cell injury (9).
Because of its vasodilator effect it modulates tissue
injury during the ischemia, and since it is a free radical it
causes tissue injury by forming secondary toxic products.
When tissue oxygen saturation is low it increases blood
flow by vasodilatation and when tissue oxygen saturation
is high it react with superoxide and forms toxic products
such as peroxynitrite (13). In gastrointestinal system,
evidence suggests that NO regulates mucosal blood flow,
mucosal protection, hemodynamic responses to liver
disease, hepatocyte synthetic function and relaxation of
the muscularis (10). In an experimental study it had been
showed that inhibition of endogenous NO formation with
N-nitro-L-arginine (L-NNA), a selective NO synthase
inhibitor, significantly aggregated macroscopic and
microscopic mucosal injury caused by ethanol, and
concurrent tratment with L-arginine, a precursor of NO,
which competetively inhibits L-NNA actions significantly
reduced the increased mucosal injury (22).
There are positive correlations between serum D(-)lactate and NO levels in patients with acute mesenteric
ischemia and small bowel obstruction. However, we could
not explain this relation with the present knowledge.
As a result, since the diagnosis is very difficult with
the clinics of acute mesenteric ischemic patients and
routine laboratory findings, we believe that serum D(-)lactate and NO measurements would be useful markers of
acute intestinal ischemia.
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